TipRanks
Go Ultimate55% OFF

UMP Healthcare Holdings Limited (0722) AI Stock Analysis

Top Page

HK:0722

UMP Healthcare Holdings Limited

(HKEX:0722)

Select Model
Rating:51Neutral
Price Target:HKD 0.39â–²(7.40% Upside)
Action:reiterated
Date:10/24/26

The score is held back primarily by the sharp 2026 operational deterioration (major revenue decline and losses). Technicals also indicate a downtrend with negative momentum. These are partially offset by a relatively stable balance sheet, still-positive free cash flow, and a high dividend yield, but profitability and trend conditions remain the key constraints.

Positive Factors
Manageable LeverageStable, moderate leverage gives UMP Healthcare financial flexibility while it addresses operating challenges. A sizeable equity base and slightly lower debt reduce balance-sheet strain, limit financing pressure, and preserve capacity to support operations or pursue growth.
Negative Factors
Severe Revenue DeclineThe exceptional revenue contraction represents a major deterioration in business scale and materially weakens the platform's ability to absorb fixed costs. Sustained recovery in customer activity and service revenue is necessary before prior operating performance can become dependable again.

UMP Healthcare Holdings Limited (0722) vs. iShares MSCI Hong Kong ETF (EWH)

-20%-15%-10%-5%0%5%10%15%20%HK:0722-17.61%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 296.00M
Dividend Yield
9.04%
Average Volume (3M)
77.66K
Price to Earnings (P/E)
-3.8
Beta (1Y)
0.23
Revenue Growth
-1.37%
EPS Growth
-334.69%
Country
Hong Kong
Employees
494
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

UMP Healthcare Holdings Limited Business Overview & Revenue Model

Company Description

UMP Healthcare Holdings Limited, an investment firm, delivers a broad spectrum of medical and wellness provisions across Hong Kong, Macau, and mainland China. The company's operations are divided into two main divisions: Corporate Healthcare Solution...

UMP Healthcare Holdings Limited Financial Statement Overview

Summary

Income statement weakness drives the score: 2026 saw a severe revenue collapse (-91.5% YoY) and a swing to net losses (net margin -10.4%) with negative EBIT margin (-9.8%). Offsetting factors include a still-manageable balance sheet (debt-to-equity ~0.21–0.24) and continued positive 2026 operating cash flow (HK$127M) and free cash flow (HK$105M), though free cash flow weakened versus the prior year.

Income Statement

42Neutral

Balance Sheet

70Positive

Cash Flow

64Positive
Financial statement breakdown
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue717.12M716.97M727.36M748.49M727.75M666.20M
Gross Profit424.51M375.02M490.61M692.25M502.69M463.95M
EBITDA28.11M26.97M143.30M161.98M178.21M168.03M
Net Income-74.64M-74.64M31.44M40.64M60.45M72.17M
Balance Sheet
Total Assets990.71M990.71M1.10B1.11B1.12B1.04B
Cash, Cash Equivalents and Short-Term Investments367.89M367.89M341.70M307.49M318.58M291.65M
Total Debt143.94M143.94M161.55M172.57M172.22M148.34M
Total Liabilities338.39M338.39M343.53M362.14M351.54M300.30M
Stockholders Equity640.21M640.21M742.63M725.94M740.55M698.65M
Cash Flow
Free Cash Flow104.73M104.73M133.76M91.54M80.71M26.40M
Operating Cash Flow127.02M127.02M145.40M148.78M190.04M110.91M
Investing Cash Flow-80.85M-80.85M4.13M-68.49M-134.09M-77.12M
Financing Cash Flow-86.01M-86.01M-100.00M-117.13M-53.67M-90.98M

UMP Healthcare Holdings Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price0.36

Price Trends

50DMA0.41Negative
100DMA0.43Negative
200DMA0.45Negative

Market Momentum

MACD-0.01Positive
RSI20.67Positive
STOCH0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0722, the sentiment is Negative. The current price of 0.36 is below the 20-day moving average (MA) of 0.39, below the 50-day MA of 0.41, and below the 200-day MA of 0.45, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 20.67 is Positive, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0722.

UMP Healthcare Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

HK:0722 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:6078HK:607862NeutralHKD 5.84B27.812.55%―1.59%-58.55%
HK:3869HK:386954NeutralHKD 467.79M-143.62-0.41%―3.16%-101.02%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HK:0722HK:072251NeutralHKD 292.35M-3.79-10.76%9.04%-1.37%-334.69%
HK:2453HK:245343NeutralHKD 489.79M-2.69-8.65%―47.93%65.94%
HK:3886HK:388641NeutralHKD 1.10B78.090.48%1.10%-3.26%―

* Healthcare Sector Average

Performance Comparison

-75%-50%-25%0%25%HK:0722HK:2279HK:3869HK:3886HK:6078HK:2453Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:0722 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:0722UMP Healthcare Holdings Limited0.36-0.07-16.67%
HK:2279Yonghe Medical Group Co., Ltd.2.100.2010.55%
HK:3869Hospital Corporation of China Ltd3.38-2.61-43.49%
HK:3886Town Health International Medical Group Ltd.0.16-0.11-40.07%
HK:6078Hygeia Healthcare Holdings Co., Ltd.9.51-3.88-29.01%
HK:2453Concord Healthcare Group Co., Ltd. Class H0.63-1.81-74.39%

UMP Healthcare Holdings Limited Corporate Events

UMP Healthcare Sets AGM to Approve Dividend, Board Slate and Share Buyback Mandate

Oct 22, 2026

UMP Healthcare Holdings Limited has convened its annual general meeting for 20 November 2026 in Hong Kong, where shareholders will review and adopt the audited consolidated financial statements and directors’ and auditor’s reports for the...

UMP Healthcare Swings to Loss as Impairments Hit Earnings and Dividend

Sep 24, 2026

UMP Healthcare Holdings Limited reported a slight 1.4% year-on-year decline in revenue to HK$716.97 million for the year ended 30 June 2026, while total assets fell 9.6% to HK$990.71 million and shareholders’ funds decreased 13.8% to HK$640.21...

UMP Healthcare Declares Final Dividend for FY2026

Sep 24, 2026

UMP Healthcare Holdings Limited has declared a final ordinary cash dividend of HKD 0.014 per share for the financial year ended 30 June 2026, underscoring its intention to return value to shareholders. The dividend is subject to shareholder approval...

UMP Healthcare Sets Board Meeting to Approve 2026 Annual Results and Consider Dividend

Sep 14, 2026

UMP Healthcare Holdings Limited has scheduled a board meeting for 24 September 2026 to review and approve the consolidated annual results for the financial year ended 30 June 2026. The board will also consider recommending a final dividend and addres...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 23, 2026